Kalbe Farma Tbk PT (KLBF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kalbe Farma Tbk PT (KLBF) has a cash flow conversion efficiency ratio of 0.040x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp956.75 Billion ≈ $56.06 Million USD) by net assets (Rp24.19 Trillion ≈ $1.42 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kalbe Farma Tbk PT balance sheet independence to measure how much of total assets are equity-financed.
Kalbe Farma Tbk PT - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Kalbe Farma Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Kalbe Farma Tbk PT to evaluate the quality of earnings relative to operating cash generation.
Kalbe Farma Tbk PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kalbe Farma Tbk PT ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Flight Centre Travel Group Ltd
AU:FLT
|
-0.051x |
|
SIMMTECH Co. Ltd
KQ:222800
|
-0.092x |
|
Shanghai Suochen Information Technology Co. Ltd. A
SHG:688507
|
N/A |
|
Anhui Jiangnan Chemical Industry Co Ltd
SHE:002226
|
0.043x |
|
Sino Horizon Holdings Ltd
TW:2923
|
-0.028x |
|
Vimian Group AB
ST:VIMIAN
|
0.080x |
|
Forvia SE
PA:FRVIA
|
0.366x |
|
Shaanxi Huaqin Technology Industry Co. Ltd. A
SHG:688281
|
N/A |
Annual Cash Flow Conversion Efficiency for Kalbe Farma Tbk PT (2000–2024)
The table below shows the annual cash flow conversion efficiency of Kalbe Farma Tbk PT from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Kalbe Farma Tbk PT market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp24.59 Trillion ≈ $1.44 Billion |
Rp4.79 Trillion ≈ $280.39 Million |
0.195x | +54.74% |
| 2023-12-31 | Rp23.12 Trillion ≈ $1.35 Billion |
Rp2.91 Trillion ≈ $170.37 Million |
0.126x | -26.28% |
| 2022-12-31 | Rp22.10 Trillion ≈ $1.29 Billion |
Rp3.77 Trillion ≈ $220.87 Million |
0.171x | +28.37% |
| 2021-12-31 | Rp21.27 Trillion ≈ $1.25 Billion |
Rp2.83 Trillion ≈ $165.59 Million |
0.133x | -42.38% |
| 2020-12-31 | Rp18.28 Trillion ≈ $1.07 Billion |
Rp4.21 Trillion ≈ $246.97 Million |
0.231x | +53.92% |
| 2019-12-31 | Rp16.71 Trillion ≈ $978.88 Million |
Rp2.50 Trillion ≈ $146.66 Million |
0.150x | -17.30% |
| 2018-12-31 | Rp15.29 Trillion ≈ $896.20 Million |
Rp2.77 Trillion ≈ $162.36 Million |
0.181x | +25.33% |
| 2017-12-31 | Rp13.89 Trillion ≈ $814.14 Million |
Rp2.01 Trillion ≈ $117.68 Million |
0.145x | -16.59% |
| 2016-12-31 | Rp12.46 Trillion ≈ $730.33 Million |
Rp2.16 Trillion ≈ $126.56 Million |
0.173x | -22.85% |
| 2015-12-31 | Rp10.94 Trillion ≈ $640.94 Million |
Rp2.46 Trillion ≈ $143.97 Million |
0.225x | -4.79% |
| 2014-12-31 | Rp9.82 Trillion ≈ $575.27 Million |
Rp2.32 Trillion ≈ $135.72 Million |
0.236x | +116.28% |
| 2013-12-31 | Rp8.50 Trillion ≈ $498.06 Million |
Rp927.16 Billion ≈ $54.33 Million |
0.109x | -41.58% |
| 2012-12-31 | Rp7.37 Trillion ≈ $431.95 Million |
Rp1.38 Trillion ≈ $80.65 Million |
0.187x | -17.44% |
| 2011-12-31 | Rp6.52 Trillion ≈ $381.81 Million |
Rp1.47 Trillion ≈ $86.34 Million |
0.226x | +13.15% |
| 2010-12-31 | Rp5.77 Trillion ≈ $338.21 Million |
Rp1.15 Trillion ≈ $67.60 Million |
0.200x | -29.78% |
| 2009-12-31 | Rp4.79 Trillion ≈ $280.71 Million |
Rp1.36 Trillion ≈ $79.90 Million |
0.285x | +53.10% |
| 2008-12-31 | Rp4.34 Trillion ≈ $254.57 Million |
Rp807.70 Billion ≈ $47.33 Million |
0.186x | +105.77% |
| 2007-12-31 | Rp4.02 Trillion ≈ $235.36 Million |
Rp362.90 Billion ≈ $21.26 Million |
0.090x | -50.02% |
| 2006-12-31 | Rp3.54 Trillion ≈ $207.67 Million |
Rp640.61 Billion ≈ $37.54 Million |
0.181x | +15.14% |
| 2005-12-31 | Rp2.81 Trillion ≈ $164.74 Million |
Rp441.37 Billion ≈ $25.86 Million |
0.157x | -45.36% |
| 2004-12-31 | Rp1.48 Trillion ≈ $86.69 Million |
Rp425.07 Billion ≈ $24.91 Million |
0.287x | -42.02% |
| 2003-12-31 | Rp1.02 Trillion ≈ $59.97 Million |
Rp507.17 Billion ≈ $29.72 Million |
0.496x | -19.13% |
| 2002-12-31 | Rp651.41 Billion ≈ $38.17 Million |
Rp399.13 Billion ≈ $23.39 Million |
0.613x | +25.47% |
| 2001-12-31 | Rp345.97 Billion ≈ $20.27 Million |
Rp168.95 Billion ≈ $9.90 Million |
0.488x | +52.08% |
| 2000-12-31 | Rp305.74 Billion ≈ $17.91 Million |
Rp98.17 Billion ≈ $5.75 Million |
0.321x | -- |
About Kalbe Farma Tbk PT
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biop… Read more